Literature DB >> 20567772

Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo.

Maria B Laursen1, Malgorzata M Pakula, Shan Gao, Kees Fluiter, Olaf R Mook, Frank Baas, Niels Langklaer, Suzy L Wengel, Jesper Wengel, Jørgen Kjems, Jesper B Bramsen.   

Abstract

Small interfering RNAs (siRNAs) are now established as a favourite tool to reduce gene expression by RNA interference (RNAi) in mammalian cell culture. However, limitations in potency, duration, delivery and specificity of the gene knockdown (KD) are still major obstacles that need further addressing. Recent studies have successfully improved siRNA performance by the introduction of several types of chemical modifications. Here we explore the effect of incorporating unlocked nucleic acid (UNA) into siRNA designs. The acyclic UNA monomers lack the C2'-C3'-bond of the RNA ribose ring and additively decrease nucleic acid duplex thermostability. We show that UNA-modifications of siRNAs are compatible with efficient RNAi and can improve siRNA performance both in vitro and in vivo. In particular, we find that the destabilizing properties of UNA are well suited to enhance the potency of siRNAs which are heavily modified by other chemical modifications such as locked nucleic acid (LNA), C4'hydroxymethyl-DNA (HM), 2'-O-methyl-RNA (OMe), DNA and 2'-Flouro-DNA (F). Interestingly, we find that naked, but UNA-modified siRNAs have dramatically increased biostability in mice and can induce potent KD in a xenograft model of human pancreas cancer. Hereby UNA constitutes an important type of chemical modification for future siRNA designs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567772     DOI: 10.1039/b918869j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  34 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 2.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

3.  Increased siRNA duplex stability correlates with reduced off-target and elevated on-target effects.

Authors:  Sebastian Petri; Anne Dueck; Gerhard Lehmann; Nicholas Putz; Sabine Rüdel; Elisabeth Kremmer; Gunter Meister
Journal:  RNA       Date:  2011-03-02       Impact factor: 4.942

4.  The application of RNAi-based treatments for inflammatory bowel disease.

Authors:  Morten Tobias Jarlstad Olesen; Borja Ballarín-González; Kenneth Alan Howard
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

5.  A Single Amide Linkage in the Passenger Strand Suppresses Its Activity and Enhances Guide Strand Targeting of siRNAs.

Authors:  Travis Hardcastle; Irina Novosjolova; Venubabu Kotikam; Samwel K Cheruiyot; Daniel Mutisya; Scott D Kennedy; Martin Egli; Melissa L Kelley; Anja van Brabant Smith; Eriks Rozners
Journal:  ACS Chem Biol       Date:  2018-01-10       Impact factor: 5.100

Review 6.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

7.  RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.

Authors:  Shaguna Seth; Yoshiyuki Matsui; Kathy Fosnaugh; Yan Liu; Narendra Vaish; Roger Adami; Pierrot Harvie; Rachel Johns; Gregory Severson; Tod Brown; Akihide Takagi; Susan Bell; Yan Chen; Feng Chen; Tianying Zhu; Renata Fam; Iwona Maciagiewicz; Erin Kwang; Michael McCutcheon; Ken Farber; Patrick Charmley; Michael E Houston; Alan So; Michael V Templin; Barry Polisky
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

Review 8.  RNAi and small interfering RNAs in human disease therapeutic applications.

Authors:  Monica R Lares; John J Rossi; Dominique L Ouellet
Journal:  Trends Biotechnol       Date:  2010-09-15       Impact factor: 19.536

9.  Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.

Authors:  Yuichiro Aiba; Jiaxin Hu; Jing Liu; Qin Xiang; Carlos Martinez; David R Corey
Journal:  Biochemistry       Date:  2013-11-27       Impact factor: 3.162

10.  A chemical perspective on transcriptional fidelity: dominant contributions of sugar integrity revealed by unlocked nucleic acids.

Authors:  Liang Xu; Steven W Plouffe; Jenny Chong; Jesper Wengel; Dong Wang
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-24       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.